Sevoflurane

Inhalation Anesthesia: Global Market Size Share & Trends Analysis Report 2019 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 7, 2019
Health, Pharmaceutical, Neurochemistry, GABAA receptor positive allosteric modulators, General anesthetics, Drugs, Chemistry, Nicotinic antagonists, Organofluorides, Ethers, Desflurane, Sevoflurane, Compound annual growth rate, Isoflurane

The "Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Isoflurane, Desflurane), By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Inhalation Anesthesia Market Size Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Isoflurane, Desflurane), By Region, And Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global inhalation anesthesia market size is projected to reach USD 1.42 billion by 2015, at a lucrative CAGR of 3.5% over the forecast period, according to this new report.
  • On the basis of product, the inhalation anesthesia market is classified into sevoflurane, isoflurane, and desflurane.
  • North America held the leading market share of USD 456.0 million and is anticipated to witness lucrative CAGR over the forecast period.

Inhalation Anesthesia: Worldwide Market Analysis Report 2018-2025 - The Increasing Concern About Greenhouse Gas Emissions is Hampering Growth

Retrieved on: 
Thursday, November 8, 2018
Chemistry, Neurochemistry, GABAA receptor positive allosteric modulators, General anesthetics, Organic chemistry, Nicotinic antagonists, Organofluorides, Ethers, Desflurane, Sevoflurane, Isoflurane, Anesthesia

The "Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Desflurane, Isoflurane), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Desflurane, Isoflurane), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global inhalation anesthesia market size is expected to reach USD 1.4 billion by 2025, exhibiting 3.5% CAGR during the forecast period.
  • Hence, these drugs are the preferred choice for patients who are critically injured and require a shorter duration of anesthesia.
  • The global inhalation anesthesia market, by product, was dominated by sevoflurane with a revenue share of 70% in 2017.

The global inhalation anesthesia market size is expected to reach USD 1.4 billion by 2025

Retrieved on: 
Tuesday, September 25, 2018
Chemistry, Neurochemistry, GABAA receptor positive allosteric modulators, General anesthetics, Nicotinic antagonists, Organofluorides, Organic chemistry, Ethers, Desflurane, Sevoflurane, Isoflurane, Compound annual growth rate

Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Desflurane, Isoflurane), And Segment Forecasts, 2018 - 2025

Key Points: 
  • Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Application (Induction, Maintenance), By Product (Sevoflurane, Desflurane, Isoflurane), And Segment Forecasts, 2018 - 2025
    The global inhalation anesthesia market size is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting 3.5% CAGR during the forecast period.
  • Hence, these drugs are the preferred choice for patients who are critically injured and require a shorter duration of anesthesia.
  • The global inhalation anesthesia market, by product, was dominated by sevoflurane with a revenue share of 70.0% in 2017.
  • North America accounted for the dominant revenue share of 40.6% in the global market in 2017, followed by Europe.

China Sevoflurane Market 2018-2022: Demand for Narcotic Drugs will Continue to Increase, Creating a Promising Market for Sevoflurane

Retrieved on: 
Wednesday, June 20, 2018
Chemistry, Neurochemistry, Health, GABAA receptor positive allosteric modulators, General anesthetics, NMDA receptor antagonists, Ethers, Nicotinic antagonists, Sevoflurane, Pharmaceutical industry in China, Pharmaceutical industry

According to the analysis, in 1996, the sevoflurane of Abbott entered the Chinese market, but currently Abbott holds a very small market share.

Key Points: 
  • According to the analysis, in 1996, the sevoflurane of Abbott entered the Chinese market, but currently Abbott holds a very small market share.
  • In 2007 and 2008, CFDA approved the inhaled solution sevoflurane of Shanghai Hengrui Pharmaceuticals and Lunan Better Pharmaceutical to go public in China.
  • It is expected that with the increasing surgery in China from 2018 to 2022, the demand for narcotic drugs will continue to increase, creating a promising future market for sevoflurane.
  • 3 Analysis of Sevoflurane Sales in China, 2013-2017
    4 Market Share of Sevoflurane Manufacturers in China, 2013-2017
    5 Major Sevoflurane Manufacturers in Chinese Market, 2017-2018
    6 Reference Sale Price of Sevoflurane Manufacturers in Hospitals, 2017-2018
    7 Prospects of Sevoflurane in China, 2018-2022